Thrombolysis in acute ischemic stroke: Controlled trials and clinical experience

Neurology

Volumn 53, Issue 7 SUPPL. 4, 1999, Pages

  Hacke, Werner ⁱ   Brott, Thomas ^a   Caplan, Louis ^b   Meier, Dieter ^c   Fieschi, Cesare ^j   Von Kummer, Rüdiger ^j   Donnan, Geoffrey ^d   Heiss, Wolf Dieter ^j   Wahlgren, Nils Gunnar ^e   Spranger, Matthias ^f   Boysen, Gudrun ^g   Marler, John R ^h  

^a MAYO CLINIC   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^g BISPEBJERG HOSPITAL   (Denmark)

^h NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

ⁱ UNIVERSITY OF HEIDELBERG   (Germany)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; PLACEBO;

BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EUROPE; FIBRINOLYTIC THERAPY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK BENEFIT ANALYSIS; UNITED STATES;

ACUTE DISEASE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED CLINICAL TRIALS; HUMANS; THROMBOLYTIC THERAPY;

EID: 0032744573     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. The NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333: 1581-1587.
2. Hacke W, Kaste M, Fieschi C, Toni D. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-1025.
3. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-1251.
4. von Kummer R. Effect of training in reading CT scans on patient selection for ECASS II. Neurology 1998;51(suppl 3): S50-52.
5. American Heart Association. 1999 heart and stroke statistical update. Dallas: American Heart Association, 1998.
6. Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke 1998;29: 415-421.
7. Brott TG, Hacke W. Thrombolytic and defibrinogenating agents for ischemic and hemorrhagic stroke. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, eds. Stroke: pathophysiology, diagnosis, and management. 3rd ed. New York: Churchill Livingstone, 1998:1155-1166.
8. Braunwald E, Knatterud GL, Passamani ER, Robertson TL. Announcement of protocol change in Thrombolysis in Myocardial Infarction Trial [letter]. J Am Coll Cardiol 1987;9:467.
9. Grond M, Stenzel C, Schmulling S, et al. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 1998;29:1544-1549.
10. Heiss WD, Grond M, Thiel A, et al. Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke. J Cereb Blood Flow Metab 1998; 18:1298-1307.
11. Caplan LR, Mohr JP, Kistler JP, Koroshetz W. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis - not a panacea for ischemic stroke. N Engl J Med 1997;337:1309-1310.
12. Fagan SC, Morgenstern LB, Petitta A, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology 1998;50:883-890.